Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect
Tarek S. Ibrahim, Mohamed M. Hawwas, Azizah M. Malebari, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 802-818
Open Access | Times Cited: 20

Showing 20 citing articles:

Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy
Mohammed Hawash
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1843-1843
Open Access | Times Cited: 67
Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors
Heba S. Mohamed, Noha H. Amin, Mohammed T. El‐Saadi, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105687-105687
Closed Access | Times Cited: 25
Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway
Jian Song, Shenghui Wang, Chun-Hong Song, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114583-114583
Closed Access | Times Cited: 25
New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAF V600E and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study
Wael A.A. Fadaly, Mohamed T. M. Nemr, Taha H. Zidan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 13
A review of recent advances in quinoline/isoquinoline based hybrids as microtubule targeted cancer therapeutics: Synthesis, binding mode, QSAR and docking studies
Paria Nasehi, Negar Omidkhah, Razieh Ghodsi
Journal of Molecular Structure (2023) Vol. 1295, pp. 136720-136720
Closed Access | Times Cited: 12
Discovery of Novel Isoquinoline Analogues as Dual Tubulin Polymerization/V-ATPase Inhibitors with Immunogenic Cell Death Induction
Jiafu Leng, Yongjun Zhao, Shifang Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 3144-3166
Closed Access | Times Cited: 4
3,4-Diarylisoxazoles─Analogues of Combretastatin A-4: Design, Synthesis, and Biological Evaluation In Vitro and In Vivo
Georgy L. Karetnikov, Lilya A. Vasilyeva, Gulalek Babayeva, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 2, pp. 384-394
Open Access | Times Cited: 3
Design, synthesis, and evaluation of anti-breast cancer activity of colchicine - combretastatin A-4 analogues containing quinoline as microtubule-targeting agents
Nam Q.H. Doan, Hoan N. Tran, Nhu T. M. Nguyen, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138465-138465
Closed Access | Times Cited: 3
Molecular target interactions of quinoline derivatives as anticancer agents: A review
Vikas Pradhan, Salahuddin Salahuddin, Rajnish Kumar, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 4, pp. 977-997
Closed Access | Times Cited: 11
Design, synthesis and anti-tumor activity of novel benzothiophenonaphthalimide derivatives targeting mitochondrial DNA (mtDNA) G-quadruplex
Qiong Huang, Xiao Wang, An Chen, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115062-115062
Closed Access | Times Cited: 9
Design, Synthesis, and Investigation of Cytotoxic Activity of cis-Vinylamide-Linked Combretastatin Analogues as Potential Anticancer Agents
Tarfah Al‐Warhi, Leena S. Alqahtani, Ghadi Alsharif, et al.
Symmetry (2022) Vol. 14, Iss. 10, pp. 2088-2088
Open Access | Times Cited: 8
Pyrazoline derivatives as tubulin polymerization inhibitors with one hit for Vascular Endothelial Growth Factor Receptor 2 inhibition
Bing Yang, Jiahua Zhou, Fa Wang, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105134-105134
Closed Access | Times Cited: 10
Design, Synthesis, and Antipoliferative Activities of Novel Substituted Imidazole-Thione Linked Benzotriazole Derivatives
Ahdab N. Khayyat, Khaled O. Mohamed, Azizah M. Malebari, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5983-5983
Open Access | Times Cited: 10
Developing our knowledge of the quinolone scaffold and its value to anticancer drug design
Yogesh Singh, Neha Bhatia, Avadh Biharee, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 10, pp. 1151-1167
Closed Access | Times Cited: 3
Synthesis and Cytotoxic Activity of Combretastatin A-4 and 2,3-Diphenyl-2H-indazole Hybrids
Jaime Pérez‐Villanueva, Félix Matadamas‐Martínez, Lilián Yépez-Mulía, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 815-815
Open Access | Times Cited: 7
Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
Chao Wang, Jing Chang, Shanbo Yang, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 5
Discovery of novel octahydroquinazoline scaffolds endowed with dual inhibition of tubulin polymerization/Eg5 against HCC: Apoptotic and radio-chemotherapeutic studies
Mohammed K. Abdelhameid, Ehab S. Taher, Mohammed A. Hara, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107449-107449
Closed Access
Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking
Heba Abdelmegeed, Lina M. A. Abdel Ghany, Amira Youssef, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22092-22112
Open Access
Discovery of novel quinazoline derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potential anti-colon cancer effects
Liqiao Zhu, Mengyu Zhang, Jiafu Leng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 117000-117000
Closed Access
Combretastatin A-4 based compounds as potential anticancer agents: A review
Moien A. Omar, Soha H. Emam, Demiana S. Mikhail, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107930-107930
Closed Access
Page 1

Scroll to top